The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Extended Antiretroviral Prophylaxis to Reduce Breast-Milk HIV-1 Transmission
Open accessAbstract
BACKGROUND: Effective strategies are urgently needed to reduce mother-to-child transmission of human immunodeficiency virus type 1 (HIV-1) through breast-feeding in resource-limited settings. METHODS: Women with HIV-1 infection who were breast-feeding infants were enrolled in a randomized, phase 3 trial in Blantyre, Malawi. At birth, the infants were randomly assigned to one of three regimens: single-dose nevirapine plus 1 week of zidovudine (control regimen) or the control regimen plus daily extended prophylaxis either with nevirapine (extended nevirapine) or with nevirapine plus zidovudine (extended dual prophylaxis) until the age of 14 weeks. Using Kaplan-Meier analyses, we assessed the risk of HIV-1 infection among infants who were HIV-1-negative on DNA polymerase-chain-reaction assay at birth. RESULTS: Among 3016 infants in the study, the control group had consistently higher rates of HIV-1 infection from the age of 6 weeks through 18 months. At 9 months, the estimated rate of HIV-1 infection (the primary end point) was 10.6% in the control group, as compared with 5.2% in the extended-nevirapine group (P<0.001) and 6.4% in the extended-dual-prophylaxis group (P=0.002). There were no significant differences between the two extended-prophylaxis groups. The frequency of breast-feeding did not differ significantly among the study groups. Infants receiving extended dual prophylaxis had a significant increase in the number of adverse events (primarily neutropenia) that were deemed to be possibly related to a study drug. CONCLUSIONS: Extended prophylaxis with nevirapine or with nevirapine and zidovudine for the first 14 weeks of life significantly reduced postnatal HIV-1 infection in 9-month-old infants. (ClinicalTrials.gov number, NCT00115648.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Statistical Methods.
Knott, M., Hollander, M., & Wolfe, D. A. (1974) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2344557 · Cited by 2,662
CD4+ Count–Guided Interruption of Antiretroviral Treatment
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,231
Wiktor, S. Z., Ekpini, E., Karon, J. M., Nkengasong, J., Maurice, C., Severin, S. T., Roels, T. H., Kouassi, M. K., Lackritz, E. M., Coulibaly, I.-M., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10412-9 · Cited by 541
(2002) · The Lancet · doi:10.1016/s0140-6736(02)08214-4 · Cited by 459
The Strategies for Management of Antiretroviral Therapy (SMART) Study Group (2008) · The Journal of Infectious Diseases · doi:10.1086/586713 · Cited by 399
Danel, C., Moh, R., Minga, A., Anzian, A., Ba-Gomis, O., Kanga, C., Nzunetu, G., Gabillard, D., Rouet, F., Sorho, S., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68887-9 · Cited by 221
Kilewo, C., Karlsson, K., Ngarina, M., Massawe, A., Lyamuya, E., Swai, A., Lipyoga, R., Mhalu, F., & Biberfeld, G. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181b323ff · Cited by 219
Taha, T. E., Kumwenda, N. I., Gibbons, A., Broadhead, R. L., Fiscus, S., Lema, V., Liomba, G., Nkhoma, C., Miotti, P. G., & Hoover, D. R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14538-2 · Cited by 205
Self-citationLeroy, V., Karon, J. M., Alioum, A., Ekpini, E. R., Meda, N., Greenberg, A. E., Msellati, P., Hudgens, M., Dabis, F., & Wiktor, S. Z. (2002) · AIDS · doi:10.1097/00002030-200203080-00016 · Cited by 167
Gray, G., Urban, M. F., Chersich, M., et al. (2005) · AIDS · doi:10.1097/01.aids.0000180100.42770.a7 · Cited by 108
Cited by
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
Baeten, J. M., Donnell, D., Ndase, P., Mugo, N. R., Campbell, J. D., Wangisi, J., Tappero, J. W., Bukusi, E. A., Cohen, C. R., Katabira, E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1108524 · Cited by 3,256
The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic
Broder, S. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.10.002 · Cited by 520
Maternal or Infant Antiretroviral Drugs to Reduce HIV-1 Transmission
Chasela, C. S., Hudgens, M. G., Jamieson, D. J., Kayira, D., Hosseinipour, M. C., Kourtis, A. P., Martinson, F., Tegha, G., Knight, R. J., Ahmed, Y. I., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0911486 · Cited by 440
(2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70288-7 · Cited by 405
Biomedical interventions to prevent HIV infection: evidence, challenges, and way forward
Padian, N. S., Buvé, A., Balkus, J., Serwadda, D., & Cates, W. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60885-5 · Cited by 264
Metadata
- Authors
- Kumwenda, N. I., Hoover, D. R., Mofenson, L. M., Thigpen, M. C., Kafulafula, G., Li, Q., Mipando, L., Nkanaunena, K., Mebrahtu, T., Bulterys, M., Fowler, M. G., & Taha, T. E.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-07-10
- Volume
- 359
- Issue
- 2
- Pages
- 119-129
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2038183880
- Cited by
- 404
- References
- 10
- FWCI
- 37.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.